NADAC acquisition cost data for APREPITANT 40 MG CAPSULE. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00781232106 | $52.79 | 2022-12-21 | Rx |
| 00781232151 | $52.79 | 2022-12-21 | Rx |
| 13668059180 | $52.79 | 2022-12-21 | Rx |
| 13668059181 | $52.79 | 2022-12-21 | Rx |
| 13668059182 | $52.79 | 2022-12-21 | Rx |
| 68462058340 | $52.79 | 2022-12-21 | Rx |
| 68462058385 | $52.79 | 2022-12-21 | Rx |
| 00781232106 | $52.79 | 2022-12-21 | Rx |
| 00781232151 | $52.79 | 2022-12-21 | Rx |
| 13668059180 | $52.79 | 2022-12-21 | Rx |
Generic: Aprepitant | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $6.4M | 9,211 | 3,646 | $145.05 |
| 2020 | $6.9M | 8,449 | 3,209 | $146.42 |
| 2021 | $7.2M | 9,232 | 3,801 | $131.67 |
| 2022 | $8.4M | 9,411 | 4,178 | $128.92 |
| 2023 | $8.6M | 9,992 | 4,705 | $124.75 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| Pennsylvania | $1.4M | 790 | 244 |
| California | $1.0M | 1,461 | 664 |
| New York | $905.7K | 1,495 | 651 |
| Florida | $591.4K | 1,263 | 556 |
| Wisconsin | $551.2K | 238 | 68 |
| Ohio | $493.2K | 327 | 170 |
| Michigan | $410.1K | 375 | 187 |
| Indiana | $359.5K | 139 | 51 |
| Texas | $338.2K | 886 | 460 |
| Massachusetts | $314.7K | 222 | 92 |
| Kentucky | $263.3K | 89 | 36 |
| Alabama | $231.7K | 349 | 132 |
| Minnesota | $189.9K | 97 | 41 |
| Puerto Rico | $186.0K | 354 | 120 |
| Illinois | $174.2K | 169 | 92 |
| Virginia | $149.7K | 89 | 42 |
| New Jersey | $131.9K | 195 | 119 |
| North Carolina | $127.1K | 159 | 104 |
| Colorado | $85.7K | 81 | 43 |
| Washington | $60.6K | 116 | 83 |
| Tennessee | $56.7K | 18 | N/A |
| Vermont | $56.4K | 19 | N/A |
| Georgia | $51.8K | 119 | 90 |
| Arizona | $40.3K | 153 | 130 |
| Missouri | $35.5K | 178 | 140 |
| Rhode Island | $34.6K | 16 | N/A |
| Maryland | $33.5K | 76 | 67 |
| Nebraska | $31.9K | 23 | 11 |
| Oregon | $29.5K | 55 | 31 |
| South Carolina | $28.9K | 51 | 43 |
| Connecticut | $28.2K | 36 | 28 |
| Maine | $27.9K | 13 | N/A |
| Idaho | $27.0K | 65 | 61 |
| New Hampshire | $24.5K | 28 | 19 |
| West Virginia | $14.3K | 17 | 14 |
| Utah | $12.1K | 23 | 13 |
| Mississippi | $11.7K | 13 | N/A |
| Iowa | $9.2K | 25 | 12 |
| Louisiana | $8.6K | 24 | 15 |
| Nevada | $8.0K | 29 | 21 |
| Oklahoma | $6.9K | 35 | 27 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.